International Network of VENous Thromboembolism Clinical Research Networks

Flag of USA


The Venous thromboEmbolism Network U.S. (“VENUS”) is a collaborative U. S. research network organized under the auspices of the Hemostasis and Thrombosis Research Society, Inc. (“HTRS”). 

The purpose of VENUS is to initiate and implement collaborative, multi-institutional, investigator-initiated clinical trials and/or other scientific research projects focused on thrombotic disorders in the United States (U.S.). VENUS members are individual physician-scientists employed at various academic medical or other non-commercial research institutions in the U.S. At present, there are an estimated 90 individual investigators employed at 60-70 institutions participating in VENUS.

VENUS members are organized into committees based on their research focus. Each VENUS committee is charged with organizing collaborative, multi-institutional research projects, including clinical trials, and applying for grant funds to support any proposed projects.

Council Members

Dr. David Garcia

Dr. David Garcia, MD

Dr. David Garcia completed internal medicine residency at the Johns Hopkins Hospital and hematology fellowship at the University of Washington. He has been Professor of Medicine at the University of Washington since 2013.

Dr. Garcia has been either an investigator or steering committee member for numerous clinical trials related to the prevention and treatment of thromboembolic disease, and he is a past-President of the Anticoagulation Forum. Dr. Garcia will be a Co-Director of the American Society of Hematology Clinical Research Training Institute for 2017-2018, and he has authored or co-authored more than 100 peer-reviewed publications in journals such as Blood, Archives of Internal Medicine, New England Journal of Medicine, the British Journal of Hematology, Stroke and Circulation. Dr. Garcia was very involved with the development of the Ninth Edition of the American College of Chest Physicians Guidelines on Anti-thrombotic Therapy and is Special Editor for Evidence-based Focused Reviews at Blood.

Dr. Lisa Baumann Kreuziger

Dr. Lisa Baumann Kreuziger, MD, MS

Lisa Baumann Kreuziger, MD is an Associate Medical Director at the BloodCenter of Wisconsin and Assistant Professor at the Medical College of Wisconsin - Division of Hematology and Oncology. She specializes in the treatment of clotting disorders and other benign hematology diseases. Dr. Baumann Kreuziger’s research interests involve optimal anticoagulation therapy for cancer patients with catheter-related thrombosis and understanding the mechanisms of thrombosis in heart failure patients with left ventricular assist devices (LVAD).


* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.